Condition: Breast Cancer · Non-small Cell Lung Cancer · Melanoma · Sponsor: BostonGene
The BEGIN Study by BostonGene and Exigent Genomic INsight evaluates the efficacy of comprehensive molecular testing in advanced cancer patients. Using the BostonGene Tumor Portrait test, the study aims to identify actionable findings, assess feasibility, and determine patient enrollment in clinical trials. Four cohorts of 100 patients each will be studied over two years, focusing on treatment decisions and patient outcomes. This study seeks to demonstrate the clinical utility of genomic testing in guiding therapy for advanced cancer patients in community settings.
This description comes directly from the study's public registry record.
Rheanna Carter, MBA · 650-773-0771 · rheanna.carter@bostongene.com
Always discuss trial participation with your own doctor first.
| Highlands Oncology Group | Rogers, Arkansas, United States | Recruiting |
| Stockton Hematology Oncology Medical Group | Stockton, California, United States | Recruiting |
| Fort Wayne Medical Oncology and Hematology | Fort Wayne, Indiana, United States | Recruiting |
| New Mexico Cancer Center | Albuquerque, New Mexico, United States | Recruiting |
| Oklahoma Cancer Specialists and Research Institute | Tulsa, Oklahoma, United States | Recruiting |
| Oncology Consultants | Houston, Texas, United States | Recruiting |
| Northwest Medical Specialities | Puyallup, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06272864